Plus Therapeutics, Inc. (PSTV)

NASDAQ: PSTV · Real-Time Price · USD

0.6980

+0.0561 (8.74%)

At close: May 13, 2025, 4:00 PM

0.7397

+0.0417 (5.97%)

Pre-market: May 14, 2025, 8:57 AM EDT

Plus Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Revenue	5.82	4.91	0.22	-	0.3	Upgrade
Revenue Growth (YoY)	18.54%	2093.30%	-	-	-95.67%	Upgrade
Cost of Revenue	10.58	9.69	9.7	5.32	2.7	Upgrade
Gross Profit	-4.76	-4.78	-9.47	-5.32	-2.4	Upgrade
Selling, General & Admin	9.94	8.54	10.24	6.85	6.41	Upgrade
Operating Expenses	9.94	8.54	10.24	6.85	6.41	Upgrade
Operating Income	-14.7	-13.32	-19.71	-12.18	-8.8	Upgrade
Interest Expense	-0.18	-0.4	-0.71	-0.93	-1.11	Upgrade
Interest & Investment Income	0.27	0.4	0.15	0.02	0.05	Upgrade
Other Non Operating Income (Expenses)	1.62	-	0	0.01	2.4	Upgrade
EBT Excluding Unusual Items	-12.98	-13.32	-20.28	-13.08	-7.46	Upgrade
Gain (Loss) on Sale of Assets	-	-	-	-0.07	-	Upgrade
Pretax Income	-12.98	-13.32	-20.28	-13.4	-8.24	Upgrade
Earnings From Continuing Operations	-12.98	-13.32	-20.28	-13.4	-8.24	Upgrade
Net Income	-12.98	-13.32	-20.28	-13.4	-8.24	Upgrade
Net Income to Common	-12.98	-13.32	-20.28	-13.4	-8.24	Upgrade
Shares Outstanding (Basic)	7	3	2	1	0	Upgrade
Shares Outstanding (Diluted)	8	3	2	1	0	Upgrade
Shares Change (YoY)	145.18%	79.45%	117.18%	173.03%	219.93%	Upgrade
EPS (Basic)	-1.95	-4.24	-11.58	-16.63	-27.92	Upgrade
EPS (Diluted)	-2.34	-4.24	-11.58	-16.65	-27.92	Upgrade
Free Cash Flow	-10.7	-13.01	-13.48	-10.42	-8.53	Upgrade
Free Cash Flow Per Share	-1.39	-4.14	-7.70	-12.93	-28.89	Upgrade
Gross Margin	-81.66%	-97.23%	-	-	-	Upgrade
Operating Margin	-252.32%	-271.14%	-8800.00%	-	-2905.28%	Upgrade
Profit Margin	-222.84%	-271.04%	-9051.34%	-	-2719.80%	Upgrade
Free Cash Flow Margin	-183.72%	-264.83%	-6018.30%	-	-2814.19%	Upgrade
EBITDA	-13.97	-12.69	-19.09	-11.78	-8.44	Upgrade
EBITDA Margin	-239.90%	-258.35%	-	-	-	Upgrade
D&A For EBITDA	0.72	0.63	0.62	0.4	0.37	Upgrade
EBIT	-14.7	-13.32	-19.71	-12.18	-8.8	Upgrade
EBIT Margin	-252.32%	-271.14%	-	-	-	Upgrade
Revenue as Reported	-	-	-	-	0.3	Upgrade

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q